Item request has been placed!
×
Item request cannot be made.
×
Processing Request
IL‐17A expressed on neutrophil extracellular traps promotes mesenchymal stem cell differentiation toward bone‐forming cells in ankylosing spondylitis.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Author(s): Papagoras, Charalampos; Chrysanthopoulou, Akrivi; Mitsios, Alexandros; Ntinopoulou, Maria; Tsironidou, Victoria; Batsali, Aristea K; Papadaki, Helen A; Skendros, Panagiotis; Ritis, Konstantinos
- Source:
European Journal of Immunology; Apr2021, Vol. 51 Issue 4, p930-942, 13p
- Subject Terms:
- Additional Information
- Abstract:
Ankylosing spondylitis (AS) is an inflammatory disease characterized by excessive bone formation. We investigated the presence of neutrophil extracellular traps (NETs) in AS and how they are involved in the osteogenic capacity of bone marrow mesenchymal stem cells (MSCs) through interleukin‐17A (IL‐17A). Peripheral neutrophils and sera were obtained from patients with active AS and healthy controls. NET formation and neutrophil/NET‐associated proteins were studied using immunofluorescence, immunoblotting, qPCR, and ELISA. In vitro co‐culture systems of AS NET structures and MSCs isolated from controls were deployed to examine the role of NETs in the differentiation of MSCs toward osteogenic cells. Analysis was performed using specific staining and qPCR. Neutrophils from patients with AS were characterized by enhanced formation of NETs carrying bioactive IL‐17A and IL‐1β. IL‐17A‐enriched AS NETs mediated the differentiation of MSCs toward bone‐forming cells. The neutrophil expression of IL‐17A was positively regulated by IL‐1β. Blocking IL‐1β signaling on neutrophils with anakinra or dismantling NETs using DNase‐I disrupted osteogenesis driven by IL‐17A‐bearing NETs. These findings propose a novel role of neutrophils in AS‐related inflammation, linking IL‐17A‐decorated NETs with the differentiation of MSCs toward bone‐forming cells. Moreover, IL‐1β triggers the expression of IL‐17A on NETs offering an additional therapeutic target in AS. [ABSTRACT FROM AUTHOR]
- Abstract:
Copyright of European Journal of Immunology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
No Comments.